Sudarshan Pharma Industries Limited (BOM:543828)
India flag India · Delayed Price · Currency is INR
41.43
-0.39 (-0.93%)
At close: Jul 27, 2026

BOM:543828 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
233.03159.55114.5570.3752.48
Depreciation & Amortization
37.8810.312.299.078.66
Other Amortization
-2.84---
Loss (Gain) From Sale of Assets
-10.2----
Loss (Gain) From Sale of Investments
-0.84----
Provision & Write-off of Bad Debts
3.97----
Other Operating Activities
225.9201.0196.1652.6633
Change in Accounts Receivable
-767.01-365.52-415.71-80.33-130.83
Change in Inventory
-758.55-526.75-97.98-276.98-229.06
Change in Accounts Payable
972.51279.68-332.55181.38295.33
Change in Other Net Operating Assets
40.31587.95720.09-244.11-67.8
Operating Cash Flow
-22.99349.0696.86-287.93-38.22
Operating Cash Flow Growth
-260.39%---

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-690.97-46.93-37.84-143.27-16.56
Sale of Property, Plant & Equipment
220.07----
Cash Acquisitions
-20.69-0.73-29.97--
Investment in Securities
--164.99-15-123.39-
Other Investing Activities
-285.3710.23-8.0310.141.99
Investing Cash Flow
-776.97-202.42-90.84-256.52-14.57

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
947.2----
Long-Term Debt Issued
101.36--78.4912.03
Total Debt Issued
1,049--78.4912.03
Long-Term Debt Repaid
-10.28-0.31-22.97--
Net Debt Issued (Repaid)
1,038-0.31-22.9778.4912.03
Issuance of Common Stock
---641.6120.19
Common Dividends Paid
---7.22--
Other Financing Activities
-246.59-143.76-91.63-60.8210.38
Financing Cash Flow
791.69-144.07-121.82659.2842.61

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
14.1----
Net Cash Flow
5.842.57-115.8114.83-10.19

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-713.96302.1359.02-431.2-54.79
Free Cash Flow Growth
-411.94%---
Free Cash Flow Margin
-10.15%5.98%1.27%-9.35%-1.53%
Free Cash Flow Per Share
-2.971.250.25-1.79-0.38
Levered Free Cash Flow
-1,077-521.19-731.33-447.11-89.26
Unlevered Free Cash Flow
-916.55-433.03-682.14-418.45-72.02

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
246.59154.7190.2854.0233.79
Cash Income Tax Paid
60.2128.4121.2221.0617.68
Change in Working Capital
-512.74-24.65-126.15-420.03-132.35